| Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
| KIDINS220 |
kinase D-interacting substrate, 220kDa |
Mapped by significant region |
|
| UBC |
ubiquitin C |
Mapped by CNV |
|
| BCAR1 |
breast cancer anti-estrogen resistance 1 |
Mapped by significant region |
|
| ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
Mapped by LD-proxy; Mapped by literature SNP |
|
| RIT2 |
Ras-like without CAAX 2 |
Mapped by significant region |
|
| MAPKAP1 |
mitogen-activated protein kinase associated protein 1 |
Mapped by significant region |
|
| RICTOR |
RPTOR independent companion of MTOR, complex 2 |
Mapped by significant region |
|
| AATF |
apoptosis antagonizing transcription factor |
Mapped by CNV |
|
| SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
Mapped by significant region |
|
| RTN4 |
reticulon 4 |
Mapped by CNV |
|
| SORT1 |
sortilin 1 |
Mapped by CNV |
IMP[14985763]
|
| RTN4R |
reticulon 4 receptor |
Mapped by CNV |
|
| RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
Mapped by significant region |
|
| ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
Mapped by PBA pathway |
|
| FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
Mapped by significant region |
|
| SMPD2 |
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase) |
Mapped by PBA pathway |
|
| ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
Mapped by CNV |
|
| SQSTM1 |
sequestosome 1 |
Mapped by CNV |
|
| PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
Mapped by significant region |
|
| MCF2L |
MCF.2 cell line derived transforming sequence-like |
Mapped by CNV |
|
| RPS6KB2 |
ribosomal protein S6 kinase, 70kDa, polypeptide 2 |
Mapped by significant region |
|
| MAPK3 |
mitogen-activated protein kinase 3 |
Mapped by CNV |
|
| ADCY4 |
adenylate cyclase 4 |
Mapped by significant region |
|
| ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
Mapped by significant region |
|
| ARHGEF4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
Mapped by CNV; Mapped by significant region |
|
| ADORA2A |
adenosine A2a receptor |
Mapped by CNV |
|
| ADAM17 |
ADAM metallopeptidase domain 17 |
Mapped by significant region |
|
| BAD |
BCL2-associated agonist of cell death |
Mapped by significant region |
|
| ARHGEF12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
Mapped by significant region |
|
| MAPK7 |
mitogen-activated protein kinase 7 |
Mapped by significant region |
|
| NDN |
necdin homolog (mouse) |
Mapped by CNV; Mapped by significant region |
|
| UBB |
ubiquitin B |
Mapped by significant region |
|
| MAPK1 |
mitogen-activated protein kinase 1 |
Mapped by LD-proxy |
|
| PRKAR2B |
protein kinase, cAMP-dependent, regulatory, type II, beta |
Mapped by CNV |
|